Background: Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacteria (NTM) infections are major health problems in Human Immunodeficiency Virus (HIV)-infected patients. Most previous studies focused mainly on tuberculosis (TB) rather than NTM infections.

Objective: To determine clinical features of mycobacterial infections, from both MTB and NTM in HIV-infected patients in Siriraj Hospital.

Material And Method: A retrospective study of adult HIV-infected patients in Infectious Disease Clinic, Siriraj Hospital, was conducted. Clinical characteristics and factors associated with mycobacterial infections were analyzed.

Results: Of 253 patients enrolled, 65 (25.7%) developed mycobacterial infections, in which 56 patients (86%) were tuberculosis (TB), whereas NTM was diagnosed in 9 (14%). Of these 65 patients, 45 (69.2%) were culture-proven, 14 (21.6%) were diagnosed TB by positive acid-fast bacilli smears and 6 (9.2%) were diagnosed TB by clinical response to anti-tuberculosis treatment only. Among culture-positive patients, MTB was found in 36 (80%) and NTM in 9 (20%), in which Mycobacterium avium complex (MAC) was the most common among NTMisolates (n = 5),followed by unidentifiable slowly-growing mycobacteria (n = 3) and M. fortuitum (n = 1). Among patients with MTB infection, 58.3% were disseminated. The most affected organ in patients with mycobacterial infections was lung (75%), followed by lymph node (66.7%). Factors associated with mycobacterial infections included male gender (64.6% vs. 54.3%; p = 0.026), higher HIV Viral load (1.04 x 10(6) VS. 0.3 x 10(6); p = 0.004), lower hematocrit (32.7% vs. 35.3%; p = 0.032) and higher alkaline phosphatase (ALP) (146 U/L vs. 107 U/L;p = 0.032). In contrast, Pneumocystis pneumonia (PCP) was negatively associated with mycobacterial infections in HIV-infected individuals (28.8% vs. 10.9%; p = 0.004). Favorable treatment response was 86.1% and 77.8% for MTB and NTM infection, respectively, and the 6-month mortality rates were 2.78% and 11.1% for MTB and NTM infection, respectively. In patients who received treatment for TB, 22.2% had hepatitis, 13.9% had drug allergy and 8.3% had immune reconstitution inflammatory syndrome.

Conclusion: Disseminated infection is the most common form of mycobacterial infection in HIV-infected patients, resulting in anemia and high ALP levels. PCP was negatively associated with mycobacterial infection. MAC is the most common of the NTM isolates in HIV-infected patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mycobacterial infections
28
hiv-infected patients
20
associated mycobacterial
16
patients
13
mtb ntm
12
mycobacterial
9
infections
8
human immunodeficiency
8
patients siriraj
8
siriraj hospital
8

Similar Publications

Tuberculosis vaccines and therapeutic drug: challenges and future directions.

Mol Biomed

January 2025

Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, 17#Heishanhu Road, Haidian District, Beijing, 100091, China.

Tuberculosis (TB) remains a prominent global health challenge, with the World Health Organization documenting over 1 million annual fatalities. Despite the deployment of the Bacille Calmette-Guérin (BCG) vaccine and available therapeutic agents, the escalation of drug-resistant Mycobacterium tuberculosis strains underscores the pressing need for more efficacious vaccines and treatments. This review meticulously maps out the contemporary landscape of TB vaccine development, with a focus on antigen identification, clinical trial progress, and the obstacles and future trajectories in vaccine research.

View Article and Find Full Text PDF

Diagnostic Accuracy of Breath Tests to Detect Pulmonary Tuberculosis: A Systematic Review.

Lung

January 2025

Department of Medicine, National University Hospital, NUHS Tower Block, Level 10, 1E Kent Ridge Road, Singapore, 119228, Singapore.

Purpose: Tuberculosis (TB) is a highly contagious infection and one of the world's leading causes of death from a single infectious agent. Currently, TB diagnosis can be established via mycobacterial cultures, Acid Fast Bacilli smear and molecular studies. In the ever-evolving landscape of medical advancements, breath tests have shown considerable promise.

View Article and Find Full Text PDF

Itaconate mechanism of action and dissimilation in .

Proc Natl Acad Sci U S A

January 2025

Centre for Tuberculosis Research, Tuberculosis Research Laboratory, Translational Health Science and Technology Institute, National Capital Region Biotech Science Cluster 3rd Milestone, Faridabad, Haryana 121001, India.

Itaconate, an abundant metabolite produced by macrophages upon interferon-γ stimulation, possesses both antibacterial and immunomodulatory properties. Despite its crucial role in immunity and antimicrobial control, its mechanism of action and dissimilation are poorly understood. Here, we demonstrate that infection of mice with increases itaconate levels in lung tissues.

View Article and Find Full Text PDF

Bacterial biofilms are surface-attached communities consisting of non-replicating persister cells encased within an extracellular matrix of biomolecules. Unlike bacteria that have acquired resistance to antibiotics, persister cells enable biofilms to demonstrate innate tolerance toward all classes of conventional antibiotic therapies. It is estimated that 50-80% of bacterial infections are biofilm associated, which is considered the underlying cause of chronic and recurring infections.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) is one of the oldest infectious diseases and continues to be a major killer of human beings. This paper was designed to provide insights into the disease burden of TB.

Methods: The data was retrieved and downloaded from the latest GBD database.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!